UBS Adjusts Yixintang Pharmaceutical Group's Price Target to 35 Yuan From 51 Yuan, Keeps at Buy
UBS Adjusts Yixintang Pharmaceutical Group's Price Target to 35 Yuan From 51 Yuan, Keeps at Buy
瑞银将一心堂药业集团的目标股价从51元调整为35元,维持买入
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册